89bio, Inc. Proceeds from Issuance Initial Public Offering
89bio, Inc. reported Proceeds from Issuance Initial Public Offering of $158.29 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2021-03-25
- 89bio, Inc. proceeds from issuance initial public offering for fiscal 2019 was $87.69M.
| Period end | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|
| 2020-09-30 | $158.29M 10-Q · filed 2020-11-13 | |
| 2019-12-31 | $87.69M 10-K · filed 2021-03-25 |